4 Ways Marketers Can Create Valuable Content That Achieves Brand Objectives
“Find exactly what your audience wants, find exactly where they spend their time, and deliver.”
Brand
Pfizer creates app for patients with depression
The connection to Pristiq is not overt in the app’s user interface, though Moodivator is featured on Pristiq’s website.
An EHR strategy can’t be measured in clicks, says Lilly exec
Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.
Lilly’s branded app for Trulicity looks to address adherence
Companies such as Eli Lilly and Medtronic have launched branded apps for their products, but experts say they don’t make sense for all medicines.
The 50-plus consumer is driven by curiosity and wonder, finds Ketchum study
In the United States, people over 50 are often stereotyped as complacent, set in their ways and extremely loyal to their preferred brands, but a new study released Tuesday by Ketchum found that the opposite is true.
Best Branded Website for Healthcare Professionals of 2016
CDM New York populated this engaging and outstanding website for Salix with unique visuals and messaging elements designed to drive awareness.
Podcast: Adherence: Leveraging Data to Enhance Your Brand’s Ability to Reach Target Patients
In this sponsored podcast, MM&M’s Larry Dobrow speaks with Robert Leedom, senior analytics consultant at TrialCard, and Paul LeVine, VP of analytic services for TrialCard, about how to reach patients by leveraging brand data.
Five things for pharma marketers to know: Wednesday, September 14, 2016
Patients who ask for a prescription after seeing an ad are more likely to get one; Mylan’s executive pay is now under scrutiny
Mylan’s branded ad spending on the EpiPen rose 357% — to $43 million in 2015 — over five years
In 2011 the drugmaker spent $9.4 million on branded ads for the EpiPen. By 2015, branded ad spending hit $43 million.
The co-pay card debate simmers, as payers push back
Will this payer pressure pose an existential threat to co-pay cards even though patients love them?
